Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar's Logo
Search 205,587,808 papers from all fields of science
Create Free Account
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
Can anti-IgE be used to treat allergy?
L. A. Gossett
Springer Seminars in Immunopathology
Corpus ID: 32440234
Summary and conclusionA summary of the properties of CGP 51901 is shown in Table 3. On the basis of its binding to IgE and IgE…
[Non-specific immunotherapy for the treatment of allergic diseases].
Polski merkuriusz lekarski : organ Polskiego…
Corpus ID: 32019584
IgE antibodies play a key role in the development of allergic reactions. Non-specific immunotherapy which enables to control the…
Efficacy, Pharmacodynamics, and Pharmacokinetics of CGP 51901, AnAnti-Immunoglobulin E Chimeric Monoclonal Antibody, in Patients withSeasonal Allergic Rhinitis
Corpus ID: 72813625
1. Racine-Poon A, 2. Botta L, 3. Chang TW, 4. et al. (1997) Clin Pharmacol Ther. 62:675–690. [OpenUrl][CrossRef][2…
The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.
The Journal of clinical investigation
Corpus ID: 13850741
CGP 51901 is a non-anaphylactogenic mouse/human chimeric anti-human IgE antibody that binds to free IgE and surface IgE of IgE…
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti‐immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitis
Clinical pharmacology and therapeutics
Corpus ID: 28652703
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE